Скачать с ютуб Duchenne UK grants US$615,056 to Catabasis Pharmaceuticals to study Edasalonexent в хорошем качестве

Duchenne UK grants US$615,056 to Catabasis Pharmaceuticals to study Edasalonexent

Duchenne UK is pleased to announce a grant of US$615,056 to Catabasis Pharmaceuticals to study Edasalonexent, a new drug for DMD to be tested in non-ambulant boys. To find out more about the project please watch this film and read our news story: https://www.duchenneuk.org/News/duche... We would like to thank our partner charities Joining Jack and Alex's Wish for supporting this project. We would also like to thank our family funds who have supported this project: Archie's March, Help Harry , Jack's Aim and Jacobi's Wish. If you have any questions about the project please email [email protected]